Wl. Rumsey et al., SPECT IMAGING OF ISCHEMIC MYOCARDIUM USING A TECHNETIUM-99M-NITROIMIDAZOLE LIGAND, The Journal of nuclear medicine, 36(8), 1995, pp. 1445-1450
This investigation evaluates the efficacy of a Tc-99m-labeled nitroimi
dazole (BMS-181321) in identifying oxygen-deprived tissue in two canin
e models of myocardial ischemia. Methods: For both models (A and B), e
picardial microvascular oxygen pressure (mPO(2)) was monitored by meas
uring the oxygen-dependent quenching of phosphorescence lifetime of Pa
lladium mesotetra (4-carboxyphenyl) porphine. In Model A (beagles, n =
5), BMS-181321 was administered intravenously and a distal branch of
the left anterior descending coronary artery (LAD) was ligated complet
ely 40 sec later. Ten minutes later, the ligature was released establi
shing tissue reoxygenation. In Model B, flow through the LAD was reduc
ed until the mPO(2) was about 2 Torr. After bolus administration of BM
S-181321 (50-60 mCi), coronary ischemia was continued for a residence
period of up to 4 hr. Results: With Model A, SPECT reconstructions rev
ealed a small ischemic area in three of five dogs, however, a transmur
al accumulation of the compound was evident in the autoradiograms from
all dogs. In the two animals in which the defect was not observed by
SPECT, the ischemic episode had nominal effects on the ratio of +/-dp/
dt (<4% change as compared to baseline values). In Model B, SPECT reco
nstructions showed positive images of the oxygen-deprived area within
the mid- to apical regions of the left ventricle (n = 5). Autoradiogra
phic analysis showed a transmural association with cells resulting in
an ischemic-to-nonischemic ratio of 3.5 +/- 0.4 (n = 4) for animals wi
th similar residence times. Conclusion: The results from both models s
uggest that BMS-181321 provides a noninvasive marker of regional ische
mia in the heart and that this compound may have clinical utility for
detection of coronary artery disease.